Question 1

What are the most cited papers from Ilya Pharma (Sweden)?

Accepted Answer

The most cited paper from Ilya Pharma (Sweden) is "Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus" (Emma Eriksson, Ioanna E. Milenova, Jessica Wenthe et al., 2017), with 156 citations. Next come "The discovery and development of topical medicines for wound healing" (113) and "Engineered bacteria to accelerate wound healing: an adaptive, randomised, double-blind, placebo-controlled, first-in-human phase 1 trial" (46).

Question 2

Which research topics does Ilya Pharma (Sweden) publish most on?

Accepted Answer

By volume in 2022-now: Virus-based gene therapy research, Cancer Research and Treatments, CAR-T cell therapy research and Viral gastroenteritis research and epidemiology.

Question 3

Which fields of science does Ilya Pharma (Sweden) work in?

Accepted Answer

In all years, 57% of research at Ilya Pharma (Sweden) is in Life Sciences, 43% in Health Sciences. Its largest fields are Medicine (43%), Biochemistry, Genetics and Molecular Biology (34%), Immunology and Microbiology (17%). It does 1.5× the world's share of Life Sciences.

Question 4

Is Ilya Pharma (Sweden)'s research output growing?

Accepted Answer

Output in 2022-2025 was 32% higher than in 2018-2021.